Risk of venous thromboembolism among subgroups of cancer patients undergoing chemotherapy: post-hoc analysis of the AVERT trial

Pas encore traduit Pas encore traduit
Catégorie Primary study
JournalInternational Society on Thrombosis and Haemostasis Congress; United States. Published in: Research and practice in thrombosis and haemostasis
Year 2020

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: b19516526badf291e161a446d33ed4bf3ae833d9
First added on: Jun 08, 2022